Published on behalf of
Thomas F. Lüscher
Bernard J. Gersh
New ESC course for Heart Failure specialists
Please click here to view the archive of previous Cardio NewsWire stories. Each item is removed from the archive after 90 days.
Stroke prevention guidelines for women
New Research prize announced
Rome to host ESC Congress 2016
THE FIRST POSTGRADUATE COURSE IN HEART FAILURE (PCHF)
A Project of the ESC Heart Academy, the ESC Heart Failure Association, the Zurich Heart House and University of Zurich
The first module of the Postgraduate course in heart Failure was held from 30 January – 1 February 2014, in Zurich Switzerland, and began with “Assessing the Heart Failure Patient”. Speakers included, John Cleland, Martin Cowie, Christian Müller, Luc Pierard, Bogdan Popescu and Peter Søgaard.
A highly motivated local faculty of consultant and resident physicians from the University Hospital Zurich, led by Frank Ruschitzka, contributed with excellent patient cases and the organisation of instructive clinical stations and rapid fire sessions.
The course, organised by the Zurich Heart House, is sponsored by the ESC Heart Academy led by the ESC Heart Failure Association and accredited at the University of Zurich for postgraduate education. There are 8 modules structured according to pathophysiology, clinical features, diagnostic investigations and patient management. This is a practical course with only few front lectures and importantly, many interactive case seminars, imaging sessions, ECG tutorials, live transmissions of diagnostic and interventional procedures and hands-on echo courses. The specific course structure makes it very practice-oriented providing clinical skills in diagnostic and therapeutic techniques, as well as knowledge.
The course duration is two years (2014-2015) as extra-occupational training and consists of eight 2.5 day modules. The total consists of 160 teaching and tutor hours, plus 140 hours of self-study including an e-learning platform with webinars and webcasts.
The next module on different types of heart failure, led by Karl Swedberg, will be held 3-5 April 2014, again in Zurich.
STROKE PREVENTION GUIDELINES FOR WOMEN
First stroke prevention guidelines for women call for female-specific stroke risk score
A female-specific stroke risk score has been recommended in the first American Heart Association / American Stroke Association guidelines for preventing stroke in women.
The authors state that such a score would include women’s unique risk factors and ‘might more accurately reflect a woman’s future risk of stroke than some of the currently available stroke risk profiles’.
The guideline focuses on the risk factors unique to women (preeclampsia, oral contraceptives, menopause, hormone replacement) and those that are more common in women (migraine with aura, obesity, metabolic syndrome, atrial fibrillation).
Recommendations are provided on how best to treat the stroke risks unique to women. For example, women over age 75 should be screened for atrial fibrillation. Women with a history of high blood pressure before pregnancy should be considered for low-dose aspirin and/or calcium supplement therapy to lower preeclampsia risks. Pregnant women with severely high blood pressure (160/110 mmHg or above) should be given BP medication, and treatment should be considered in those with moderately high BP (150-159 mmHg/100-109 mmHg).
The authors advocate further research on risk profile development so that prevention strategies tailored to women can be developed.
The full guidelines are available here.
NEW RESEARCH PRIZE FOR ARVC / DYSPLASIA
The Zurich ARVC Program announces the first ARVC Research Prize, for the best clinical or basic science research in Arrhythmogenic Right Ventricular Cardiomyopathy / Dysplasia
Established in 2011 at the Cardiac Arrhythmia Service of the University Heart Center in Zurich, Switzerland, the Zurich ARVC Program aims to increase awareness for this challenging disease. The programme focuses on providing clinical excellence for the care of these patients and promoting in-depth clinical and basic research for this condition at an international level. Programme directors are Professors Corinna Brunckhorst MD and Firat Duru MD both at Zurich University Hospital.
Corinna Brunckhorst MD
Zurich ARVC Program
Firat Duru MD
The Zurich ARVC Program is supported by the Georg and Bertha Schwyzer-Winiker Foundation which has made possible the creation of a new prize for ARVC research. The ARVC researcher with the most outstanding and pioneering recent contribution for ARVC published or in-press, will be awarded the ARVC Research Prize. The prize consists of 25,000 Swiss Francs and an invitation to the Zurich ARVC symposium 2014, with hotel and travel costs.
The prize-winner will be selected from amongst the candidates by a selection committee composed of international key opinion leaders in this field. The award ceremony will be held at the Second International ARVC Symposium in Zurich, Switzerland, on 18 September, 2014.
ARVC researchers are invited to send their applications to firstname.lastname@example.org prior to the deadline of 15 August, 2014.
NEW ADDITIONS TO THE EHJ
The EHJ is ranked second among premiere cardiology journals with an impact factor that soared to 14.097 in 2013.
The EHJ is now being presented on a new web platform, publishing papers on similar topics in Focus Issues, further expanding the portfolio of EHJ Today videos and adding to the team new Associate Editors in the fields of heart failure, imaging and basic science.
In addition, manuscript transfer with the European Journal of Cardio-Thoracic Surgery has been established. With regular updates through newsletters, social media and more, cardiologists now have access to highly topical and novel new data published in the EHJ faster than ever before.
The editorial team hope the EHJ will remain the cutting edge source of cardiology for cardiologists, providing them with up-to-date information in the field and their journal of choice in scientific publishing.
The editorial team are strongly committed to further improving the quality of the EHJ and strengthening its global position as a weekly journal of the highest calibre.
ROME TO HOST ESC CONGRESS FOR THE FIRST TIME
The ESC Congress 2016 will take place from 27 - 31 August 2016 at the Fiera di Roma, Italy
The President of Fiera Roma, Mauro Mannocchi explained: “Fiera Roma, which opened in 2006, is a modern, environmentally friendly and efficient exhibition venue. Fiera Roma looks forward to being the meeting point for the most eminent cardiologists in the world. We are fully equipped to receive this prominent scientific event and we are of course, totally committed to making this a unique experience for ESC Congress 2016 delegates.”
Reference (1) Information on past ESC Congress attendance and abstract submissions: http://www.escardio.org/congresses/past_congresses/Pages/past-ESC-congresses.aspx
Open access options for authors visit Oxford Open